Skip to main content
Coeptis Therapeutics Holdings, Inc. logo

Coeptis Therapeutics Holdings, Inc. — Investor Relations & Filings

Ticker · COEP ISIN · US19207A2078 US Manufacturing
Filings indexed 308 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country US United States of America
Listing US COEP

About Coeptis Therapeutics Holdings, Inc.

https://coeptistx.com/

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company that develops innovative cell therapy platforms. The company's primary focus is on creating treatments for cancer, with additional development programs targeting autoimmune and infectious diseases. Its pipeline includes advanced technologies such as CAR-T cell therapies, aimed at addressing significant unmet medical needs and improving patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Regulatory Filings
2026-05-22 English
CURRENT REPORT
Regulatory Filings
2026-05-20 English
FORM 10-Q FOR MAR 2026
Interim / Quarterly Report Q1 2026
2026-05-14 English
8-K - Z Squared Inc. (0001759186) (Filer)
Regulatory Filings
2026-05-01 English
8-K - Coeptis Therapeutics Holdings, Inc. (0001759186) (Filer)
Regulatory Filings
2026-04-28 English
25-NSE - Coeptis Therapeutics Holdings, Inc. (0001759186) (Subject)
Delisting Announcement
2026-04-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.